The Honourable Greg Hunt served in the Australian Government as Minster for Health and Aged Care from 2017, previously as Industry, Innovation and Science Minister and before that the Environment Minister.
Elected as the Member for Flinders in 2001, Greg announced his retirement from politics late 2021 and in 2022, ahead of the Federal Election, having completed 20 years as a public servant.
Australian Health Journal recently caught up with Greg in a relaxed interview at his home in the Mornington Peninsula, Victoria to hear how a 9 month sabbatical has allowed him to focus on family, fitness and future. This has even included some “brutal spin cycle classes!”.
In his Ministerial role, Greg reflects on the critical supply of masks, gloves, gowns, tests, vaccines and ventilators during the initial years of the COVID-19 pandemic.
Greg talks about Australia’s sovereign capability in a post-COVID-19 world which has played a part on delivering 98% vaccine uptake across Australians, and with some of the lowest rates of death from COVID. He references the structural platform in place with the Medical Research Future Fund, R&D Tax Concession and the Patent Box.
Looking ahead, precision health as a service, stem cells and genomics are key trends that will define the future workforce through targeted treatments, according to Greg. He states with optimism that innovation, research and investment, can make the country a global leader.
He’s also is optimistic the country is well placed with the quality of the workforce, the training in place and the balance between public and private health.
In conclusion Greg, talks to you, the health industry on the support he received both in office and after, and thanks the industry for the treatment delivered to every Australian patient.
Now Greg is moving his attention to 3 pillars – Academic, Philanthropic and Commercial.
Today Greg is the foundation Chair of the Turner Institute for Brain and Mental Health’s Advisory Council, at Monash University in Melbourne. The Turner Institute is a world leader in research dedicated to preventative brain and mental health research, treatment and education, a focus for Greg.
Australian Health Journal wishes Greg the best in his future endeavours.
-
Alfred Hospital leading in pharmacy services for critically unwell patients
Cristina Roman, is the Lead Pharmacist at Alfred Emergency Trauma Centre. In her 12 years working in the Emergency Department, Cristina has established pharmacy services, and filled gaps in patient care with new models of care.
One of those models of care adopted by the US and other countries, is involving pharmacists for critically unwell patients that present to the emergency department.
Australian Health Journal spoke with Cristina Roman and Lisa Bremner, Advanced Training Resident Pharmacist at Alfred Hospital Emergency Trauma Centre.
-
Australian Healthcare Week 2019: Pitch Fest Finalist Coviu
Telelheath startup company Coviu was a Pitch Fest Finalist at last week’s Australian Healthcare Week Expo in Sydney. The Coviu platform has been developed as an spinoff from CSIRO and allows healthcare businesses offer video consultations to their own patients. It differs from being just a ‘talking head’ platform that Skype or Zoom could offer, by providing clinical tools integrated within the app. Anne Dao spoke with Co-founder and CEO Silvia Pfeiffer about the company and platform’s journey to date and its longer term goals.
Coviu helps healtcare businesses by helping fit in more consultation during that day and reducing no-shows for appointments. Also given the nature of the dispersed population, the application reaches to rural and regional areas where patients are a long distance from their healthcare provider. The company is focused on the Australian market and aims to enter the US market next year
-
Closing the diagnostic gap in ovarian cancer detection
After 15 years in academia, Associate Professor Michelle Hill founded ProSeek bio to address one of the most urgent challenges in women’s health: closing the diagnostic gap in ovarian cancer.
For too long, women suspected of ovarian cancer have faced an impossible choice — undergo invasive surgery for diagnosis, only for up to 80% of those procedures to reveal no cancer, or delay intervention and risk diagnosis at a later stage when treatment options are fewer and survival outcomes are significantly worse.
